ArticleiScience2026
Penetrating potential evaluation of cyclotriphosphazenes target blood-brain barrier via computational toxicology methods.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclotriphosphazenes (CTPs), widely used as lithium-ion battery electrolyte additives, are increasingly recognized as environmental contaminants with potential neurotoxicity. We developed an integrated computational framework to evaluate the blood-brain barrier (BBB) penetration potential and neurotoxic mechanisms of CTPs. Six representative CTPs were predicted to penetrate the BBB via passive diffusion and impair BBB function. Among them, HPCTP, PFPCTP, HCCTP, and HFCTP primarily disrupted BBB function through inhibition of ATP-binding cassette transporters. HPCTP exhibited the strongest BBB-disrupting potential, primarily through interactions with SLC2A1 and SLC6A3 and through the modulation of BBB-related gene expression. Experimental validation in hCMEC/D3 cells showed that HPCTP impaired glucose transport and utilization and significantly downregulated SLC2A1 expression. These findings provide a strategy for assessing BBB penetration of exogenous chemicals and highlight the potential CNS risks associated with environmental CTP exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.